In contrast, another study conducted on 80 individuals, including a healthy control group, found that serum ATG-5 levels were significantly lower in individuals diagnosed with hepatocellular carcinoma compared to the control group. The gene discussed is ATG5; the disease is hepatocellular carcinoma.